ADC Pipeline Analysis Report: Drugs & Development 2026
What are antibody-drug conjugates, and why are they important in oncology pipelines? Antibody-drug conjugates (ADCs) are innovative cancer therapies that combine monoclonal antibodies with cytotoxic drugs. They specifically target tumor-associated antigens, delivering potent agents directly to cancer cells while minimizing damage to healthy tissue. As the global cancer burden is projected to...
0 Σχόλια 0 Μοιράστηκε 28 Views 0 Προεπισκόπηση